Primum non nocere and the quality of evidence: Rethinking the ethics of screening

Journal of the American Board of Family Practice

Volumn 13, Issue 3, 2000, Pages 188-196

  Ewart, Robert M ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EVIDENCE BASED MEDICINE; HEALTH CARE AND PUBLIC HEALTH; HUMAN; LEGAL ASPECT; MASS SCREENING; MEDICAL ETHICS; PROFESSIONAL PRACTICE; PUBLIC HEALTH; REVIEW; RISK ASSESSMENT; SOCIAL JUSTICE; STANDARD;

HEALTH CARE AND PUBLIC HEALTH;

ETHICS, MEDICAL; EVIDENCE-BASED MEDICINE; HUMANS; MASS SCREENING; PROFESSIONAL AUTONOMY; PUBLIC HEALTH; RISK ASSESSMENT; SOCIAL JUSTICE;

EID: 0034185464     PISSN: 08938652     EISSN: None     Source Type: Journal    
DOI: 10.3122/15572625-13-3-188     Document Type: Article

References (43)

1. Skrabanek P. Why is preventive medicine exempted from ethical constraints? J Med Ethics 1990;16:187-90.
2. Horner JS. Medical ethics and the public health. Public Health 1992;106:185-92.
3. McCormick J. Health promotion: the ethical dimension. Lancet 1994;344:390-1.
4. Weil JG, Hawker JI. Positive findings of mammography may lead to suicide. BMJ 1997;314:754-5.
5. Sackett DL, Haynes, RB, Guyatt GH, Tugwell P. Clinical epidemiology: a basic science for clinical medicine. 2nd ed. Boston: Little, Brown; 1991:154-70.
6. Mant D, Fowler G. Mass screening: theory and ethics. BMJ 1990;300:916-8.
7. Taplin SH, Mandelson MT. Principles of cancer screening for clinicians. Prim Care 1992;19:513-33.
8. Miller AB. The public health aspects of screening: principles and ethical aspects. In: Miller AB, editor. Advances in cancer screening. Boston: Kluwer Academic Publications; 1996:3.
9. Gillon R. Utilitarianism. Br Med J (Clin Res Ed) 1985;290:1411-3.
10. Rose G. Strategy of prevention: lessons from cardiovascular disease. Br Med J (Clin Res Ed) 1981;282: 1847-51.
11. Stewart-Brown S, Farmer A. Screening could seriously damage your health: decisions to screen must take account of the social and psychological costs. BMJ 1997;314:533-4.
12. Woolf SF. Screening for prostate cancer with prostate-specific antigen. An examination of the evidence. N Engl J Med 1995;333:1401-5.
13. Cribb A, Haran D. The benefits and ethics of screening for breast cancer. Public Health 1991;105:63-7.
14. Gillon R. Medical ethics: four principles plus attention to scope. BMJ 1994;309:184-8.
15. Haynes RB, Sackett DL, Taylor DW, Gibson ES, Johnson AL. Increased absenteeism from work after detection and labeling of hypertensive patients. N Engl J Med 1978;299:741-4.
16. Stoate HG. Can health screening damage your health? J R Coll Gen Pract 1989;39:193-5.
17. Gillon R. "Primum non nocere" and the principle of non-maleficence. Br Med J (Clin Res Med) 1985; 291:130-1.
18. Gillon R. Beneficence: doing good for others. Br Med J (Clin Res Med) 1985;291:44-5.
19. Faden RR, Beauchamp TL, King NMP. A history and theory of informed consent. New York: Oxford University Press; 1986.
20. Gillon R. Autonomy and the principle of respect for autonomy. Br Med J (Clin Res Med) 1985;290: 1806-8.
21. Gillon R. Consent. Br Med J (Clin Res Med) 1985; 291:1700-1.
22. Edwards PJ, Hall DM. Screening, ethics, and the law. BMJ 1992;305:267-8.
23. Gillon R. Justice and medical ethics. Br Med J (Clin Res Med) 1985;291:201-2.
24. Gillon R. Justice and allocation of medical resources. Br Med J (Clin Res Med) 1985;291:266-8.
25. Drummond MF, Mooney GH. Essentials of health economics. Part V - Assessing the costs and benefits of treatment alternatives. Br Med J (Clin Res Med) 1982;285:1561-3.
26. Crisp R, Hope T, Ebbs D. The Ashbury draft policy on ethical use of resources. BMJ 1996;312:1528-31.
27. New B. The rationing agenda in the NHS. Rationing Agenda Group. BMJ 1996;312:1593-601.
28. The Canadian guide to clinical preventive health care. Canadian Task Force on the Periodic Health Examination. Ottawa: Canada Communications Group, 1986:xxv-xxxvi.
29. Guide to clinical preventive services: report of the US Preventive Services Task Force. 2nd ed. Baltimore: Williams & Wilkins; 1996:xxxix-lv, 861-2.
30. Epstein LH. The direct effects of compliance on health outcome. Health Psychol 1984;3:385-93.
31. Semiglasov VF, Moiseenko VM, Protsenko SA, et al. [Preliminary results of the Russia (St. Petersburg)/ WHO program for the evaluation of the effectiveness of breast self-examination.] Vopr Onkol 1996; 42(4):49-55.
32. Kronborg O, Fenger C, Olsen J, Jørgensen OD, Søndergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467-71.
33. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348:1472-7.
34. Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. Results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 1998;279:1615-22.
35. Morris M. Preinvasive lesions of the female genital tract. In: Kase N, Weingold AB, Gershenson DM., editors. Principles and practice of clinical gynecology. 2nd ed. New York: Churchill Livingstone, 1990:801-25.
36. Sasieni P, Adams J. Effect of screening on cervical cancer mortality in England and Wales: analysis of trends with an age period cohort model. BMJ 1999; 318:1244-5.
37. Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990;335:827-38.
38. Singer P, McKie J, Kuhse H, Richardson J. Double jeopardy and the use of QALYs in health care allocation. J Med Ethics 1995;21:144-50.
39. Harris J. Double jeopardy and the veil of ignorance - a reply. J Med Ethics 1995;21:151-7.
40. Leplège A, Hunt S. The problem of quality of life in medicine. JAMA 1997;278:47-50.
41. Daniels N. Is the Oregon rationing plan fair? JAMA 1991;265:2232-5.
42. Maynard A, Bloor K. Introducing a market to the United Kingdom's National Health Service. N Engl J Med 1996;344:604-8.
43. Stronks K, Strijbis AM, Wendte JF, Gunning-Schepers LJ. Who should decide? Qualitative analysis of panel data from public, patients, Healthcare professionals, and insurers on priorities in health care. BMJ 1997;315:92-6.